Qyuns Therapeutics Co., Ltd. (02509.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 16.57

From 52W high−52.60%

Volume17600.00

Market capHKD 3.75B

P/E (TTM)5.9x

P/S (TTM)3.1x

Div yield—

Key dataSep 18, 2026

Open

HKD 16.57

From 52W high

−52.60%

Volume

17600.00

Market cap

HKD 3.75B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.9x

P/E (TTM)

5.9x

RSI (14)

52.7

MomentumView details →

1D Return

+1.09%

YTD Return

−10.81%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

5.9x

EV/EBITDA

4.9x

EV/Sales

2.8x

P/S (TTM)

3.1x

P/B (TTM)

3.7x

ProfitabilityView details →

Gross Margin

88.64%

Net Margin

53.30%

EBITDA Margin

56.74%

ROE (TTM)

63.42%

ROA (TTM)

28.58%

Asset Turnover

0.54x

GrowthView details →

Revenue YoY

+219.81%

EPS YoY

+378.93%

FCF YoY

+341.75%

Revenue CAGR 3Y

+333.31%

EPS CAGR 3Y

+189.54%

EBITDA YoY

+471.01%

MomentumView details →

1D Return

+1.09%

YTD Return

−10.81%

1Y Return

−43.56%

RSI (14)

52.7

vs 50D SMA

+0.99%

vs 200D SMA

−7.08%

Capital & dividendView details →

Debt/Equity

0.80x

Current Ratio

2.29x

Quick Ratio

2.18x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

HKD 1.05

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.02B

Net Income (TTM)

546.10M

Op. CF (TTM)

519.90M

Next earningsMar 26, 2027 →

Latest newsMore news →

Caldera Therapeutics obtained commitments for a concurrent private placement of approximately $278 million from a syndicate of leading healthcare institutional investors and mutual funds to support the proposed merger.53d ago

Caldera Therapeutics entered into a definitive merger agreement for an all-stock merger with Synlogic, becoming wholly owned subsidiaries of a new holding company, and the combined company will operate as Caldera Therapeutics, Inc. and list on Nasdaq under ticker CALD.53d ago

Similar companies

IDEAYA Biosciences, Inc.IDYA Tango Therapeutics, Inc.TNGX Mirxes Holding Company Limited02629.HK Tarsus Pharmaceuticals, Inc.TARS Xenon Pharmaceuticals Inc.XENE Catalyst Pharmaceuticals, Inc.CPRX Find similar companies →

Latest newsMore news →

Caldera Therapeutics obtained commitments for a concurrent private placement of approximately $278 million from a syndicate of leading healthcare institutional investors and mutual funds to support the proposed merger.53d ago Caldera Therapeutics entered into a definitive merger agreement for an all-stock merger with Synlogic, becoming wholly owned subsidiaries of a new holding company, and the combined company will operate as Caldera Therapeutics, Inc. and list on Nasdaq under ticker CALD.53d ago